Human Blood Cell Disorders Tissue Bank
| Status: | Recruiting |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 4/6/2019 |
| Start Date: | April 2009 |
| End Date: | January 2025 |
| Contact: | Yasmine Kieso, MSCR |
| Email: | ykieso@nshs.edu |
The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of
tissue containing populations of human blood cells from patients with various types of
lymphoid, myeloid, and erythroid proliferative diseases as well as other associated
conditions. The tissue bank will continue to be an invaluable asset for understanding of the
biology of multiple blood cell disorders involving several cell types as well as the
physiology of normal cellular counterparts affected in these disorders. Internal and external
investigators will be able to utilize this tissue to test hypotheses relating to the
immunologic, virologic, genetic, and molecular properties of these abnormal cells as well as
normal cells from normal unaffected family members or normal aged matched subjects to provide
better comparisons.
tissue containing populations of human blood cells from patients with various types of
lymphoid, myeloid, and erythroid proliferative diseases as well as other associated
conditions. The tissue bank will continue to be an invaluable asset for understanding of the
biology of multiple blood cell disorders involving several cell types as well as the
physiology of normal cellular counterparts affected in these disorders. Internal and external
investigators will be able to utilize this tissue to test hypotheses relating to the
immunologic, virologic, genetic, and molecular properties of these abnormal cells as well as
normal cells from normal unaffected family members or normal aged matched subjects to provide
better comparisons.
Inclusion Criteria:
- Participants or participant's Legally Authorized Representatives (LAR) must be able to
understand and render voluntary, written informed consent.
- Patients must be able to contribute the required amount of blood and/or tissue without
compromising their well-being or care.
- Participants must be willing to be contacted again for consideration of additional
studies in the future, such as a blood draw or another action (e.g., bone marrow
aspiration and/or biopsy) that would be done as part of their standard of care.
Exclusion Criteria:
- Patients who are known to be anemic, with hemoglobin <8.0g/dl.
- Patients who are known to be infected with HIV.
We found this trial at
1
site
Manhasset, New York 11030
Principal Investigator: Nicholas Chiorazzi, M.D.
Click here to add this to my saved trials
